CN111135122A - Composition containing ganoderma lucidum extract and application thereof in moisturizing and anti-wrinkle cosmetics - Google Patents
Composition containing ganoderma lucidum extract and application thereof in moisturizing and anti-wrinkle cosmetics Download PDFInfo
- Publication number
- CN111135122A CN111135122A CN202010156003.XA CN202010156003A CN111135122A CN 111135122 A CN111135122 A CN 111135122A CN 202010156003 A CN202010156003 A CN 202010156003A CN 111135122 A CN111135122 A CN 111135122A
- Authority
- CN
- China
- Prior art keywords
- ganoderma lucidum
- composition
- extract
- lucidum extract
- ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of cosmetics, in particular to a composition containing ganoderma lucidum extract and application thereof in a moisturizing and anti-wrinkle cosmetic. A composition containing Ganoderma extract comprises Ganoderma extract and Ganoderma spore oil as effective components; wherein the mass ratio of the ganoderma lucidum extract to the ganoderma lucidum spore oil is (2.5-5): 1. the ganoderma lucidum extract and the ganoderma lucidum spore oil contained in the composition have good effect of improving skin elasticity through reasonable matching, improve skin darkness, improve skin vitality, relieve fine wrinkles and make skin bright; and the product has better cold and hot stability, safety and absorption feeling.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a composition containing ganoderma lucidum extract and application thereof in a moisturizing and anti-wrinkle cosmetic.
Background
The Ganoderma extract has antiaging and metabolism balance regulating effects. The contained polysaccharide and polypeptide components can enhance the disease resistance, and simultaneously can promote the synthesis of DNA in cell nucleus to achieve the effect of delaying senility. In addition, the composition can effectively reduce cholesterol, lipoprotein and triglyceride in blood fat, soften blood vessel, increase blood flow of coronary artery, protect myocardial ischemia, and prevent and treat coronary heart disease.
At present, many researches show that the ganoderma lucidum extract has certain effects of beautifying, protecting skin and moisturizing, but the cosmetics containing the ganoderma lucidum extract on the market are very few, so that the cosmetics are fewer for moisturizing and anti-wrinkle products, and the stability and the irritation of the products cannot be ensured. Therefore, there is an urgent need to develop a cosmetic containing ganoderma lucidum extract, which is safe and stable, can rapidly permeate and absorb the skin, and has the effects of moisturizing and improving the skin elasticity, and repairing facial wrinkles.
Disclosure of Invention
In order to solve the above technical problems, the present invention provides, in a first aspect, a composition comprising a ganoderma lucidum extract, comprising a ganoderma lucidum extract and ganoderma lucidum spore oil as effective ingredients; wherein the mass ratio of the ganoderma lucidum extract to the ganoderma lucidum spore oil is (2.5-5): 1.
as a preferable technical scheme, the content of the effective components is 5-20% by the total weight of the composition.
As a preferable technical scheme, the composition also comprises a thickening agent, a humectant and water.
As a preferred technical solution, the thickener is at least one selected from carbomer, poloxamer and modified cellulose.
As a preferable technical scheme, the carbomer is selected from at least one of 981, 940, 941, 934, U20, U21, TR-1 and TR-2.
As a preferable technical scheme, the humectant is at least one selected from sodium hyaluronate, polysaccharide and caprylyl hydroximic acid.
As a preferred technical scheme, the weight average molecular weight of the polysaccharide is 85-300 ten thousand.
As a preferred embodiment, the composition is used for improving skin elasticity, moisturizing and anti-wrinkle.
According to a second aspect of the invention, the skin care product of the composition containing the ganoderma lucidum extract is provided, and the weight percentage of the composition containing the ganoderma lucidum extract in the skin care product is 0.2-80%.
As a preferable technical scheme, the skin care product comprises a softening agent, a skin nutrient solution, a face cleaning cream, a nutrient cream, a massage cream, an essence, a gel cream, a facial mask, a lotion, a honey powder, a blush, an eye shadow, a mascara, a concealer, a lipstick, a lip gloss and a foundation.
Has the advantages that: the ganoderma lucidum extract and the ganoderma lucidum spore oil contained in the composition have good effect of improving skin elasticity through reasonable matching, improve skin darkness, improve skin vitality, relieve fine wrinkles and make skin bright; and the product has better cold and hot stability, safety and absorption feeling.
Drawings
FIG. 1: example 3 canthus skin elasticity results before and after use of the product.
Detailed Description
Unless otherwise indicated, implied from the context, or customary in the art, all parts and percentages herein are by weight and the testing and characterization methods used are synchronized with the filing date of the present application. To the extent that a definition of a particular term disclosed in the prior art is inconsistent with any definitions provided herein, the definition of the term provided herein controls.
The technical features of the technical solutions provided by the present invention are further clearly and completely described below with reference to the specific embodiments, and the scope of protection is not limited thereto.
The words "preferred", "preferably", "more preferred", and the like, in the present invention, refer to embodiments of the invention that may provide certain benefits, under certain circumstances. However, other embodiments may be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, nor is it intended to exclude other embodiments from the scope of the invention. The sources of components not mentioned in the present invention are all commercially available.
In order to solve the above technical problems, the present invention provides, in a first aspect, a composition comprising a ganoderma lucidum extract, comprising a ganoderma lucidum extract and ganoderma lucidum spore oil as effective ingredients; wherein the mass ratio of the ganoderma lucidum extract to the ganoderma lucidum spore oil is (2.5-5): 1.
preferably, the content of the effective component is 5-20% by the total weight of the composition. More preferably, the content of the effective component is 5-10% by total weight of the composition.
Ganoderma lucidum extract
Ganoderma lucidum (Ganoderma lucidum) has been known in China as "rotten mushrooms" and has been used in oriental medicine for over 2000 years. It is prepared by fermenting Ganoderma with Ganoderma process, and mainly contains Ganoderma triterpene compounds and Ganoderma polysaccharides.
The ganoderma lucidum triterpenoid (triorponoids) has the effects of resisting cancers, promoting liver functions, resisting allergy, resisting inflammation and relieving pain, but has unstable properties, and can be oxidized and volatilized in the air for 2 hours to lose efficacy.
The ganoderan contains glucose, and most of the ganoderan also contains other monosaccharides such as arabinose, xylose, galactose, fucose, mannose and the like. The literature reports that: more than 100 kinds of ganoderan are separated from Ganoderma lucidum, Ganoderma sinense, Ganoderma tsugae and other Ganoderma fungus, and 4 kinds of polysaccharides with strong antitumor activity are peptidoglycan. The structure of ganoderma lucidum polysaccharide contains more glycosidic bonds, which may be the reason for strong pharmacological activity.
Ganoderma spore oil
The Ganoderma spore oil is oily lipid extracted from wall-broken Ganoderma spore by supercritical carbon dioxide fluid extraction technology, and integrates multiple active ingredients of Ganoderma spore. It is yellow transparent liquid, mainly contains saturated fatty acid and unsaturated fatty acid, contains small amount of ganoderic acid, and has effects of resisting cerebral ischemia/reperfusion injury, resisting oxidation and scavenging free radicals.
Thickening agent
Preferably, the thickening agent is at least one selected from carbomers, poloxamers and modified celluloses.
Preferably, the carbomer is selected from at least one of 981, 940, 941, 934, U20, U21, TR-1 and TR-2.
The carbomer 981 is a cross-linked polyacrylate polymer and has the characteristics of long rheology, low viscosity, high transparency and good suspension stability. Carbomer U20 is a hydrophobically modified, crosslinked acrylate copolymer. In addition to the high thickening, suspending, etc. functions of traditional carbomer resins, the carbomer resin can self-wet and disperse within minutes, provide moderate to high viscosity, and have high thickening performance over a wide pH range.
Preferably, the thickening agent is carbomer 981 and carbomer U20 according to the mass ratio of (3-4): 1 is obtained by compounding.
Preferably, the thickener is present in an amount of 0.2 to 1.5% by weight based on the total weight of the composition.
Moisture-retaining agent
Preferably, the humectant is at least one selected from sodium hyaluronate, polysaccharide and caprylyl hydroximic acid.
The sodium hyaluronate was purchased from Shanghai European thawing organism and was of oligopeptide HA type.
The polysaccharide is one or more selected from trehalose, tremella polysaccharide and betaine.
Preferably, the weight average molecular weight of the polysaccharide is 85 to 300 ten thousand.
When the tremella polysaccharide is adopted as the humectant, the tremella polysaccharide with the weight average molecular weight of more than 100 ten thousand is preferably adopted, the molecular weight of the tremella polysaccharide has a typical acetyl structure, and the moderate molecular weight and the polyhydroxy and acetyl structures finally improve the moisturizing and water locking functions. However, since the higher the molecular weight, the higher the viscosity, the total weight of the humectant should be controlled to 6 parts or less to prevent the formation of a transparent gel.
The tremella polysaccharide is purchased from north Heibo Korea biotechnology limited.
Preferably, the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the betaine to the caprylyl hydroximic acid is 2: 1: 1: 0.5.
preferably, the humectant is present in an amount of 0.2 to 1.5% by weight of the total composition.
In order to further improve the ultraviolet protection effect, the composition of the present invention may contain an organic ultraviolet absorber. The organic ultraviolet absorber is not particularly limited.
Examples of the ultraviolet absorbers of benzoic acid type include p-aminobenzoic acid (hereinafter abbreviated as PABA), glyceryl PABA, ethyl dihydroxypropyl PABA, N-ethoxylated PABA ethyl ester, N-dimethyl PABA butyl ester, N-dimethyl PABA amino ester and octyl dimethyl PABA. the ultraviolet absorbers of anthranilic acid type include homomenthyl (homomenthyl) -N-acetyl anthranilate.salicylic acid type ultraviolet absorbers include amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate and p-isopropyl phenyl salicylate.cinnamic acid type ultraviolet absorbers include octyl, ethyl-4-isopropyl, ethyl-2, 4-diisopropyl, methyl-2, 4-diisopropyl cinnamate, isopropyl p-methoxy cinnamate, p-methoxy cinnamic acid, p-methoxy amyl cinnamate, p-methoxy-2, 4-isopropyl cinnamate, p-methoxy-2, 4-diisopropyl benzoate, p-methoxy-2, 4-isopropyl cinnamate, p-methoxy-2, 4-octyl cinnamate, p-methoxy-octyl benzoate, p-methoxy-benzoyl-2-octyl benzoate, p-methoxy-2-octyl benzoate, p-octyl benzoate, 2-methoxy-octyl benzoate, p-2-methoxy-octyl benzoate, p-2-octyl benzoate, p-methoxy-octyl benzoate, p-octyl benzoate, 3-methoxy-octyl benzoate, p-2-octyl benzoate, 3-methoxy-octyl benzoate, 3-methoxy-3-octyl benzoate, 3-methoxy-3-octyl benzoate, p-methoxy-octyl benzoate, 3-methoxy-3-methoxy-3-methoxy-3-methoxy-phenyl-3-methoxy-phenyl-3-methoxy-3-ethyl-3-methoxy-3-phenyl-methoxy-phenyl-3-methoxy-3-phenyl-methoxy-3-methoxy-phenyl-methoxy-3-phenyl-3-methoxy-2-methoxy-.
The content of the organic ultraviolet absorber in the composition is not limited, but is preferably 0.1 to 25% by weight, more preferably 0.5 to 10% by weight, of the entire composition, in order to enhance the ultraviolet protection effect and provide a good feeling in use.
The composition of the present invention may further comprise a skin whitening agent or a plant extract having a skin whitening effect. As skin whitening agent, ascorbic acids, hydroquinones, kojic acids and placenta extract can be used. Examples of the ascorbic acids include L-ascorbic acid, L-ascorbic acid glycoside and alkali metal salts of L-ascorbic acid phosphate. Examples of the hydroquinones include condensates between saccharides and alkylhydroquinones obtained by introducing an alkyl group having 1 to 4 carbon atoms into hydroquinone. Examples of kojic acids include kojic acid, kojic acid monobutyrate ester, kojic acid fatty acid ester. Examples of the placenta extract include placenta extract.
Examples of the plant extracts having a skin whitening effect include extracts of licorice, pueraria lobata, black soybean, edible tulip (amanaeidoli), common Anemarrhena rhizome (Anemarrhena), ophiopogon root (dowarflilyurus), Sansevieria (Sansevieria), Quercus salicina (Quercus salicina), artemisia capillaris (artemisia capillaris floras), chamomile (oil-soluble and water-soluble), sanguisorba officinalis (sanguisorba officinalis extract), artichoke, aster, rice, clove, turmeric, balsam pear, yam, aloe, tea, saxifraga (meadow savixiflora), scutellaria, loquat, bitter orange, ginseng, hollyhock, cinchona, lithospermum, rosemary, henbane, gulia (Sargassum), sanguisorba (burnet), and blueberry.
Among these whitening agents, preferable are chamomile extract, sanguisorba extract, tea extract, puerariae radix extract, glycyrrhiza radix extract, althea officinalis extract, sanguisorba extract (burnet extract), caryophylli flos extract, L-ascorbic acid, L-ascorbyl glycoside, kojic acid, and placenta extract. These extracts are added to the composition of the present invention in an amount of 0.001 to 5 wt%.
The cosmetic composition of the present invention may further contain components generally used in cosmetic compositions, such as liquid oils, solid fats (waxes), semi-solid oils, alcohols, water, moisturizers, water-soluble polymers, oil-soluble polymers, polymer latexes, various surfactants, drugs, plant extracts, ceramides, blood circulation improvers, cooling agents, antiperspirants, bactericides, skin activators (skin activators), pH adjusters, thickeners, antioxidants, preservatives, and perfumes.
The cosmetic composition can be used in various skin care products, and the weight percentage of the composition containing the lucid ganoderma extract in the skin care products is 0.2-80%. As such skin care products, they are suitable for use as skin softeners, skin lotions, face cleansers, nourishing creams, massage creams, essences, gel creams, face masks, lotions, honeys, blushes, eye shadows, mascaras, concealers, lipsticks, lip gloss, foundations.
The present invention is described in detail below with reference to examples, which are provided for the purpose of further illustration only and are not to be construed as limiting the scope of the present invention, and the insubstantial modifications and adaptations thereof by those skilled in the art based on the teachings of the present invention will still fall within the scope of the present invention.
Example 1
Embodiment 1 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, which comprises the following components in parts by weight: 2.5 parts of ganoderma lucidum extract, 0.5 part of ganoderma lucidum spore oil, 0.2 part of thickening agent, 3 parts of humectant and 45 parts of water.
The thickening agent is carbomer 981 and carbomer U20 according to the mass ratio of 3: 1, compounding to obtain;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the betaine to the caprylyl hydroximic acid is 2: 1: 1: 0.5.
example 2
Embodiment 2 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, which comprises the following components in parts by weight: 5 parts of ganoderma lucidum extract, 2 parts of ganoderma lucidum spore oil, 1 part of thickening agent, 6 parts of humectant and 70 parts of water.
The thickening agent is carbomer 981 and carbomer U20 in a mass ratio of 4: 1, compounding to obtain;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the betaine to the caprylyl hydroximic acid is 2: 1: 1: 0.5.
example 3
Embodiment 3 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, comprising, by weight: 3.5 parts of ganoderma lucidum extract, 1 part of ganoderma lucidum spore oil, 0.5 part of thickening agent, 5 parts of humectant and 55 parts of water.
The thickening agent is carbomer 981 and carbomer U20 in a mass ratio of 4: 1, compounding to obtain;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the betaine to the caprylyl hydroximic acid is 2: 1: 1: 0.5.
example 4
Embodiment 4 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, comprising, by weight: 3.5 parts of ganoderma lucidum extract, 1 part of ganoderma lucidum spore oil, 0.5 part of thickening agent, 5 parts of humectant and 55 parts of water.
The thickening agent is carbomer 981;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the betaine to the caprylyl hydroximic acid is 2: 1: 1: 0.5.
example 5
Embodiment 5 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, comprising, by weight: 3.5 parts of ganoderma lucidum extract, 1 part of ganoderma lucidum spore oil, 0.5 part of thickening agent, 5 parts of humectant and 55 parts of water.
The thickening agent is carbomer U20;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the betaine to the caprylyl hydroximic acid is 2: 1: 1: 0.5.
example 6
Embodiment 6 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, comprising, by weight: 3.5 parts of ganoderma lucidum extract, 1 part of ganoderma lucidum spore oil, 0.5 part of thickening agent, 5 parts of humectant and 55 parts of water.
The thickening agent is carbomer 981 and carbomer U20 in a mass ratio of 4: 1, compounding to obtain;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the betaine to the caprylyl hydroximic acid is 2: 1: 0.5.
example 7
Embodiment 7 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, comprising, by weight: 3.5 parts of ganoderma lucidum extract, 1 part of ganoderma lucidum spore oil, 0.5 part of thickening agent, 5 parts of humectant and 55 parts of water.
The thickening agent is carbomer 981 and carbomer U20 in a mass ratio of 4: 1, compounding to obtain;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the caprylyl hydroximic acid is 2: 1: 0.5.
example 8
Embodiment 8 provides a moisturizing and anti-wrinkle composition containing ganoderma lucidum extract, comprising, by weight: 3.5 parts of ganoderma lucidum extract, 1 part of ganoderma lucidum spore oil, 0.5 part of thickening agent, 5 parts of humectant and 55 parts of water.
The thickening agent is carbomer 981 and carbomer U20 in a mass ratio of 4: 1, compounding to obtain;
the humectant is a mixture of sodium hyaluronate, tremella polysaccharide, betaine and caprylyl hydroximic acid, wherein the mass ratio of the sodium hyaluronate to the tremella polysaccharide to the betaine to the caprylyl hydroximic acid is 2: 8: 1: 0.5.
performance testing
The test method comprises the following steps: preparing the moisturizing and anti-wrinkle composition into eye cream, and preparing 52.5% of the moisturizing and anti-wrinkle composition, 0.1% of chlorphenesin, 0.02% of EDTA2Na 0.02, 0.2% of 10% of NaOH, 0.02% of essence and the balance of water into emulsion according to the weight percentage; the emulsions obtained in the examples were subjected to a heat and cold stability test and also to a viscosity test.
1. Heat resistance stability test
The emulsion was maintained at 40. + -. 1 ℃ for 24 hours, and after returning to room temperature, it was observed whether there was no oil-water separation before the test, ○ indicates no separation, and X indicates separation.
2. Cold resistance stability test
Keeping the emulsion at-8 + -2 deg.C for 24h, and observing whether there is no obvious character difference after returning to room temperature compared with the previous test, wherein ○ indicates no difference, and x indicates difference.
3. Absorption sensing test
0.02g of the lotion was applied evenly to the same area of skin and the rate of absorption of the product was evaluated.
TABLE 1
| Examples | Heat resistance | Cold resistance | Sensation of absorption |
| Example 1 | ○ | ○ | Good effect |
| Example 2 | ○ | ○ | Good effect |
| Example 3 | ○ | ○ | Is excellent in |
| Example 4 | × | × | Is excellent in |
| Example 5 | × | ○ | Is excellent in |
| Example 6 | × | ○ | In general |
| Example 7 | × | ○ | In general |
| Example 8 | ○ | × | In general |
4. Skin elasticity test
1) The test method comprises the following steps: three measurements were made of the emulsion of example 3 on both sides of the external canthus of the subject using a skin elasticity tester, Cutometer dual MPA580, the control group being clear water.
2) Description of the principle of the test apparatus: the test principle is based on the principle of suction and stretching, where a negative pressure is generated on the skin surface to be tested to suck the skin into a specific test probe, and the depth of the skin sucked into the test probe is measured by a non-contact optical test system. The test probe includes a transmitter and receiver of light, the ratio of which (the ratio of the transmitted light to the received light) is proportional to the depth of the skin into which it is sucked, and then analyzed by MPA software to determine the elastic properties of the skin. Skin elasticity index R2, R2 ═ Ua/Uf.
3) The results of the tests are given in the following table
| Product(s) | Base value (Baseline) | After 14 days (D14) | After 28 days (D28) |
| Emulsion and method of making | 0.49±0.00 | 0.49±0.00 | 0.56±0.00 |
| Control group | 0.54±0.00 | 0.55±0.00 | 0.56±0.00 |
Data in table mean ± standard error
Statistical method analysis was performed using the t-test method, test level α ═ 0.05.
Significance labeling method: "n.s." means no statistical difference, p > 0.05; "+" indicates significant difference, 0.01< p < 0.05; "x" indicates a very significant difference, 0.001< p < 0.01; "x" indicates there was a very significant difference, p < 0.001.
Number of people using product 66.
Figure 1 is the results of skin elasticity before and after use of the product, where n.s. "means no statistical difference, representing 0.01< p < 0.05; represents 0.001< p < 0.01; represents p < 0.001.
Interpretation of the results:
1. after continuous use of the emulsion test product of example 3, the facial skin elasticity values were not significantly different at day 14 of product use (p >0.05) and increased very significantly at day 28 of product use (0.001< p < 0.01).
2. After continuous use of the control product, the facial skin elasticity values were not significantly different at both day 14 and day 28 of product use (p > 0.05).
Measurement values: the closer the skin elasticity value is to 1, the better the skin elasticity is.
Claims (10)
1. A composition containing Ganoderma lucidum extract comprises Ganoderma lucidum extract and Ganoderma lucidum spore oil as effective components; wherein the mass ratio of the ganoderma lucidum extract to the ganoderma lucidum spore oil is (2.5-5): 1.
2. the composition of claim 1, wherein the content of the active ingredient is 5-20% by weight of the total composition.
3. The ganoderma lucidum extract-containing composition of claim 1, further comprising a thickening agent, a humectant, water.
4. The ganoderma lucidum extract-containing composition of claim 3, wherein the thickening agent is at least one selected from the group consisting of carbomers, poloxamers, and modified celluloses.
5. The ganoderma lucidum extract-containing composition according to claim 4, wherein the carbomer is at least one selected from the group consisting of 981, 940, 941, 934, U20, U21, TR-1, TR-2.
6. The composition of any one of claims 1-5, wherein the humectant is selected from at least one of sodium hyaluronate, polysaccharide, caprylyl hydroxamic acid.
7. The ganoderma lucidum extract-containing composition of claim 6, wherein the weight average molecular weight of the polysaccharide is from 85 to 300 ten thousand.
8. The ganoderma lucidum extract-containing composition according to any one of claims 1 to 7, wherein the composition is for improving skin elasticity, moisturizing and anti-wrinkle.
9. A skin care product comprising the composition containing ganoderma lucidum extract according to any one of claims 1 to 8, wherein the weight percentage of the composition containing ganoderma lucidum extract in the skin care product is 0.2 to 80%.
10. The skin care product of claim 9, wherein the skin care product comprises a softening agent, a skin nutrient solution, a cleansing cream, a nourishing cream, a massage cream, an essence, a gel cream, a mask, a lotion, a honey powder, a blush, an eye shadow, a mascara, a concealer, a lipstick, a lip gloss, a foundation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010156003.XA CN111135122A (en) | 2020-03-09 | 2020-03-09 | Composition containing ganoderma lucidum extract and application thereof in moisturizing and anti-wrinkle cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010156003.XA CN111135122A (en) | 2020-03-09 | 2020-03-09 | Composition containing ganoderma lucidum extract and application thereof in moisturizing and anti-wrinkle cosmetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111135122A true CN111135122A (en) | 2020-05-12 |
Family
ID=70528430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010156003.XA Withdrawn CN111135122A (en) | 2020-03-09 | 2020-03-09 | Composition containing ganoderma lucidum extract and application thereof in moisturizing and anti-wrinkle cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111135122A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112826765A (en) * | 2021-01-19 | 2021-05-25 | 中科健康产业集团江苏药业有限公司 | Ganoderma spore hair care essential oil for promoting hair growth and preparation method thereof |
| FR3110413A1 (en) * | 2020-04-20 | 2021-11-26 | L'oreal | SKIN CARE COMPOSITION |
| CN115317524A (en) * | 2022-07-06 | 2022-11-11 | 周述松 | Process for breaking cell wall and extracting core of ganoderma lucidum spore powder |
| CN115381744A (en) * | 2021-10-08 | 2022-11-25 | 上海禾向健康科技发展有限公司 | Ganoderma lucidum fermentation liquor composition and application thereof in anti-aging and moisturizing skin care products |
-
2020
- 2020-03-09 CN CN202010156003.XA patent/CN111135122A/en not_active Withdrawn
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3110413A1 (en) * | 2020-04-20 | 2021-11-26 | L'oreal | SKIN CARE COMPOSITION |
| CN112826765A (en) * | 2021-01-19 | 2021-05-25 | 中科健康产业集团江苏药业有限公司 | Ganoderma spore hair care essential oil for promoting hair growth and preparation method thereof |
| CN112826765B (en) * | 2021-01-19 | 2022-08-09 | 中科健康产业集团江苏药业有限公司 | Ganoderma spore hair care essential oil for promoting hair growth and preparation method thereof |
| CN115381744A (en) * | 2021-10-08 | 2022-11-25 | 上海禾向健康科技发展有限公司 | Ganoderma lucidum fermentation liquor composition and application thereof in anti-aging and moisturizing skin care products |
| CN115381744B (en) * | 2021-10-08 | 2024-03-26 | 上海禾向健康科技发展有限公司 | Ganoderma lucidum fermentation liquor composition and application thereof in anti-aging, moisturizing and skin care products |
| CN115317524A (en) * | 2022-07-06 | 2022-11-11 | 周述松 | Process for breaking cell wall and extracting core of ganoderma lucidum spore powder |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111135122A (en) | Composition containing ganoderma lucidum extract and application thereof in moisturizing and anti-wrinkle cosmetics | |
| CN105395458B (en) | Herbal composition and application thereof | |
| KR101779999B1 (en) | Topical skin care formulation | |
| WO2021017846A1 (en) | Enhanced anti-aging cosmetic composition | |
| WO2020024703A1 (en) | Water-soluble fullerene topical composition | |
| CN105434323B (en) | Saccharomycetes to make fermentation compound and its application in skin whitening, moisturizing skin care item | |
| CN108969444B (en) | Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof | |
| CN108653142A (en) | A kind of moisture-keeping composition | |
| CN111166683A (en) | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof | |
| CN111840161A (en) | Anti-aging brightening composition and application and preparation method thereof | |
| CN110755328A (en) | Beautifying, moisturizing and repairing composition and application thereof | |
| CN113398016A (en) | Skin soothing and repairing composition and cosmetic composition | |
| CN110691630A (en) | Use of extract of rambutan peel for moisturizing skin and/or mucous membranes | |
| CN113116755A (en) | Skin care composition for promoting penetration and preparation method and application thereof | |
| CN110946784A (en) | Skin care composition with functions of improving skin barrier function and enhancing skin health | |
| CN115252500A (en) | Skin care composition containing peony extract and application thereof | |
| KR20080079802A (en) | Composition of skin external application for moisturizing comprising scrophularia buergeriana miq. extract | |
| CN110302091B (en) | Composition containing nicotinamide adenine dinucleotide for resisting skin aging and preparation method and application thereof | |
| CN110115691B (en) | Whitening and skin-tendering emulsion containing rice fermentation product and preparation method thereof | |
| CN112773761B (en) | Cosmetic composition, essence and preparation method thereof | |
| JP2006193427A (en) | Hydrogenated retinoids or hydrogenated retinoid derivative and utilization thereof | |
| CN111388394A (en) | Biphase freeze-dried powder solvent and preparation method and application thereof | |
| CN115317385A (en) | Foundation make-up composition and preparation method thereof | |
| KR101945402B1 (en) | Emulsion Containing Sea Buckthorn Oil And Cosmetic Composition For Moisturizing Skin Comprising The Same | |
| JP4076477B2 (en) | Skin preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200512 |
|
| WW01 | Invention patent application withdrawn after publication |